Thrivent Financial For Lutherans Concert Pharmaceuticals, Inc. Transaction History

Thrivent Financial For Lutherans

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$5.71 - $9.22 $403,108 - $650,904	-70,597 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $205,558 - $431,743	-34,959 Reduced 33.12%	70,597 $415,000
Q2 2019 Aug 13, 2019	BUY	$9.44 - $13.12 $12,847 - $17,856	1,361 Added 1.31%	105,556 $1.27 Million
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $27,929 - $40,587	2,314 Added 2.27%	104,195 $1.26 Million
Q4 2018 Feb 15, 2019	BUY	$11.25 - $16.17 $4,241 - $6,096	377 Added 0.37%	101,881 $1.28 Million
Q3 2018 Nov 15, 2018	SELL	$12.82 - $17.88 $156,878 - $218,797	-12,237 Reduced 10.76%	101,504 $1.51 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $10,333 - $13,299	614 Added 0.54%	113,741 $1.91 Million
Q1 2018 May 08, 2018	BUY	$19.24 - $28.03 $2.18 Million - $3.17 Million	113,127 New	113,127 $2.59 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.